2009e-publications@bond (Bond University)Requires access

Valsartan and amlodipine combination therapy for the treatment of hypertension

L. G. Howes

Open publisher page 0 citations

Abstract

Extract: Studies have consistently shown that most patients with hypertension require two or more antihypertensive agents to control their blood pressure. This had led to the introduction of fixed-dose combination therapies that enable two antihypertensive drugs to be administered in the one tablet. These fixed-dose combinations, typically of ACE inhibitors or angiotensin receptor antagonists combined with diuretics, have become commonly used therapies in Australia because they offer the promise of greater patient acceptance and compliance than the individual drugs given alone. However, recent studies have suggested that either an ACE inhibitor or an angiotensin receptor antagonist combined with a calcium channel blocker may provide better pressure control and superior outcomes than combinations that contain a diuretic.

About this research paper

What this paper is about

Extract: Studies have consistently shown that most patients with hypertension require two or more antihypertensive agents to control their blood pressure. This had led to the introduction of fixed-dose combination therapies that enable two antihypertensive drugs to be administered in the one tablet. These fixed-dose combinations, typically of ACE inhibitors or angiotensin receptor antagonists combined with diuretics, have become commonly used therapies in Australia because they offer the promise of greater patient acceptance and compliance than the individual drugs given alone. However, recent studies have suggested that either an ACE inhibitor or an angiotensin receptor antagonist combined with a calcium channel blocker may provide better pressure control and superior outcomes than combinations that contain a diuretic.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Extract: Studies have consistently shown that most patients with hypertension require two or more antihypertensive agents to control their blood pressure. This had led to the introduction of fixed-dose combination therapies that enable two antihypertensive drugs to be administered in the one tablet. These fixed-dose combinations, typically of ACE inhibitors or angiotensin receptor antagonists combined with diuretics, have become commonly used therapies in Australia because they offer the promise of greater patient acceptance and compliance than the individual drugs given alone. However, recent studies have suggested that either an ACE inhibitor or an angiotensin receptor antagonist combined with a calcium channel blocker may provide better pressure control and superior outcomes than combinations that contain a diuretic.

Key concepts: Medicine, Amlodipine, Valsartan, Combination therapy, Hypertension treatment, Internal medicine, Pharmacotherapy, Cardiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Valsartan and amlodipine combination therapy for the treatment of hypertension — Research Paper | ScholarLens